| 1. |
Stress urinary incontinence in women − therapeutic options |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 2. |
Spondylarthritis treatment guidelines released, discussed |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 3. |
Initiative to tackle counterfeit drugs announced by US FDA |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 4. |
Lower costs with sequential high-dose chemotherapy in breast cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 5. |
Rofecoxib introduction in Italy affects prescribing, costs in OA |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 6. |
Memantine improves outlook, cuts healthcare costs in AD |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 7-8
L Hunt,
Preview
|
|
摘要:
Alzheimer's disease (AD) is a disorder characterised by a progressive deterioration of physical and mental functions, which can lead to reduced patient autonomy and quality of life (QoL). Memantine, an uncompetitive NMDA receptor antagonist, enhances autonomy in patients with moderate-to-severe AD, according to the results of a study presented at the 156th Annual Meeting of the American Psychiatric Association [San Francisco, US; May 2003].1The investigators who conducted the study commented that this result"could explain the lower societal costs for memantine-treated patients".Another study presented at the meeting showed that memantine is cost effective, and offers cost savings, compared with standard care.2
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 7. |
Posaconazole*successfully treated mucormycosis in a heart-kidney transplant recipient, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 8. |
Ximelagatran is as effective as standard enoxaparin sodium plus warfarin therapy for venous thromboembolism (VTE), |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 9. |
Microsatellite-instability predicts fluorouracil efficacy in colon cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 10. |
What's the difference between SARS and ARDS? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1397,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
